In order to verify the antiviral potential of TRIM32 in vitro, EPC cells with TRIM32 transient overexpression were infected with SVCV at a multiplicity of infection (MOI) of 0.1, and SVCV production was determined by TCID50 assay at four different p.i. time points. This evidence concerns the gene TRIM32 and infection.